DNA repair in resistance to alkylating anticancer drugs.
about
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1In vivo Comparative Studies on Antigenotoxicity of Date Palm (Phoenix Dactylifera L.) Pits Extract Against DNA Damage Induced by N-Nitroso-N-methylurea in MiceLong Non-Coding RNAs: The Key Players in Glioma PathogenesisExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesNSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer CellsThe role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma responseThe Changes in MGMT Promoter Methylation Status in Initial and Recurrent GlioblastomasEthnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1Evidence for base excision repair processing of DNA interstrand crosslinks.Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors.Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.Chemical composition, antioxidant and antigenotoxic activities of different fractions of Gentiana asclepiadea L. roots extract.Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysisHistone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.
P2860
Q24300362-7BCEB002-50E1-45E4-83A4-F09F3A530F18Q24594273-2689E6C4-1E23-419E-96BD-B49F068C084EQ26800873-CC41F05E-E9A2-4B4B-B5CE-2F96F8CE8CBDQ26828930-258EAD2E-8563-4DC5-AC8B-B904F1EFEA40Q28546932-DB01C872-0205-4071-BF31-EBAEA25E9310Q33578787-FABF0F59-D57C-4A15-A3A0-97FD7CC137C0Q34354462-370659D9-84C6-45D4-B287-935A28293E70Q34525704-374DCCC1-47EB-41EE-8AE4-4DF656A7887CQ36310665-101E97C6-B98B-4299-8655-26086ABA94FEQ36607842-0F6E55D6-3348-4504-8DBB-B453144D66A1Q36799848-581CBB15-E3DF-4DF2-8583-2D2BB70511A2Q37148924-136D38A6-78A1-4F4F-BA6F-CDFB387D4435Q37510186-87C11AE1-CA43-4B47-A9BB-391C3B164DE9Q40258082-BA3E5CBD-3803-4E9E-BA95-EB9118D11F5FQ41460315-A985C3FB-177D-4C34-A05B-A1662538F53DQ42108435-692DB2C1-BBF6-4D14-B8B7-449494CCE6B6
P2860
DNA repair in resistance to alkylating anticancer drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
DNA repair in resistance to alkylating anticancer drugs.
@ast
DNA repair in resistance to alkylating anticancer drugs.
@en
type
label
DNA repair in resistance to alkylating anticancer drugs.
@ast
DNA repair in resistance to alkylating anticancer drugs.
@en
prefLabel
DNA repair in resistance to alkylating anticancer drugs.
@ast
DNA repair in resistance to alkylating anticancer drugs.
@en
P1476
DNA repair in resistance to alkylating anticancer drugs.
@en
P2093
P304
P577
2002-08-01T00:00:00Z